Becker Capital Management Inc. grew its position in shares of CME Group Inc (NASDAQ:CME) by 144.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 4,886 shares of the financial services provider’s stock after purchasing an additional 2,884 shares during the quarter. Becker Capital Management Inc.’s holdings in CME Group were worth $804,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Dubuque Bank & Trust Co. lifted its holdings in CME Group by 83.1% in the first quarter. Dubuque Bank & Trust Co. now owns 152 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 69 shares during the period. Resources Investment Advisors Inc. lifted its holdings in CME Group by 2,800.0% in the fourth quarter. Resources Investment Advisors Inc. now owns 145 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 140 shares during the period. Ruggie Capital Group acquired a new stake in CME Group in the fourth quarter worth about $28,000. Smith Asset Management Group LP lifted its holdings in CME Group by 200.0% in the fourth quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after purchasing an additional 100 shares during the period. Finally, Truvestments Capital LLC acquired a new stake in CME Group in the first quarter worth about $32,000. 84.69% of the stock is owned by institutional investors.

Shares of NASDAQ CME opened at $186.80 on Friday. CME Group Inc has a twelve month low of $157.21 and a twelve month high of $197.08. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $66.34 billion, a price-to-earnings ratio of 27.39, a price-to-earnings-growth ratio of 4.27 and a beta of 0.32.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.60 by $0.02. CME Group had a net margin of 42.47% and a return on equity of 9.29%. The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same period in the prior year, the company earned $1.86 EPS. CME Group’s revenue was up 6.4% on a year-over-year basis. On average, equities research analysts forecast that CME Group Inc will post 6.62 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be issued a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.61%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s payout ratio is 43.99%.

Several equities research analysts recently weighed in on CME shares. Bank of America set a $180.00 price objective on shares of CME Group and gave the stock a “hold” rating in a report on Tuesday, April 9th. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 8th. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target on shares of CME Group in a report on Friday, February 15th. Barclays upped their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a report on Thursday. Finally, Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $190.00.

In other CME Group news, COO Julie Holzrichter sold 4,362 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $182.45, for a total transaction of $795,846.90. Following the sale, the chief operating officer now owns 41,265 shares in the company, valued at approximately $7,528,799.25. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Jeffrey M. Bernacchi sold 10,087 shares of the business’s stock in a transaction dated Tuesday, February 26th. The stock was sold at an average price of $177.94, for a total value of $1,794,880.78. Following the sale, the director now owns 42,004 shares in the company, valued at approximately $7,474,191.76. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 43,449 shares of company stock worth $7,665,179. Corporate insiders own 1.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Becker Capital Management Inc. Has $804,000 Stake in CME Group Inc (CME)” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://theolympiareport.com/2019/05/24/becker-capital-management-inc-has-804000-stake-in-cme-group-inc-cme.html.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: Bull Market

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.